CLINICAL RESEARCH CENTERS
IAVI recognized early on that to develop effective AIDS vaccines for use throughout the world, it would be essential to build partnerships and bolster capacity to conduct vaccine trials at the highest technical and ethical standards in developing countries, where the need for a vaccine is greatest.
Today, a network of independent but interconnected research centers in five sub-Saharan African countries (Kenya, Rwanda, South Africa, Uganda and Zambia), as well as India and the UK, play a central role in IAVI's vaccine development program, testing HIV vaccine candidates and conducting epidemiological studies that inform the design of candidates and provide baseline information for future efficacy trials.
This partnership-based approach emphasizes building capacity by training local researchers and developing the infrastructure required for all such research. Investigators within this network are linked to scientific consortia—such as the Center for HIV/AIDS Vaccine Immunology and the Neutralizing Antibody Consortium—and collaborate closely with IAVI researchers.
To learn more about the clinical trials and epidemiological studies conducted at these clinical research centers, visit the IAVI Studies Database.
IAVI's Clinical Research Center Partners:
Aurum Institute, South Africa
Kenya AIDS Vaccine Initiative-Institute for Clinical Research
Kenya Medical Research Institute-Centre for Geographic Medicine Research-Coast
Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS
National AIDS Research Institute, India
National Institute for Research in Tuberculosis, India
Projet San Francisco, Rwanda
St. Stephen’s AIDS Trust, United Kingdom
University of Surrey, United Kingdom
Uganda Virus Research Institute-International AIDS Vaccine Initiative HIV Vaccine Program
University of KwaZulu-Natal HIV Pathogenesis Programme, South Africa
YR Gaitonde Centre for AIDS Research and Education, India
Zambia Emory HIV Research Project